Search

The biotechnology company Oxolife S.L. (Spain), the Energy Balance, Puberty and Reproductive Health research group of the University of Cordoba (UCO, Spain) and the Human Growth and Reproductive

AlphaFold 2, a new Artificial Intelligence platform, is being hailed as the most important advance thus far and our members have started working with it. We spoke with some of them

BetaScreen's technology is based on an algorithm capable of interpreting image biomarkers from Magnetic Resonance and CT scans, which allows to identify the presence of abnormal levels of Alzheimer's

Farmaprojects , a company specialising in the supply of generic pharmaceutical specialities, has opened a GMP-Certified Laboratory in the Barcelona Science Park for the importation and release of

Along with Elena, Maite Agüeros Bazo was awarded as Businesswoman of Navarre 2021 and Susana Sánchez as Entrepreneur of Navarre 2021.

Primary objectives: to assess the effect of vafidemstat to address negative and cognitive symptoms in schizophrenia Phase IIb adaptive trial planning to enroll 100 patients Second Phase IIb study of

Rocío Arroyo, CEO of Amadix and coordinator of the AseBio Personalised Medicine Workgroup, highlighted the role biotechnology companies play throughout the R&D cycle

Iadademstat consistently stronger in viability reduction in AML & SCLC cells Superior target engagement at low concentration in AML & SCLC cells Superior disruption of the Snag-domain protein-protein

This Thursday is the next-to-last day of COP26 and the association believes it is important to remember that biotechnology can cut greenhouse-gas emissions up to 65% and has a direct impact on 11 of

IUL presents a new fluorescence lateral flow reader in the framework of the Advanced Lateral Flow Conference in San Diego 2021. iPeak® Europium represents a fundamental advance in the lateral flow

BCN HEALTH conducted a retrospective study based on the records of patients hospitalized due to pneumococcal disease and treated in Spanish public and private hospitals between January of 2008 and

Aura Biosciences, Inc. is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates (VDCs) to target and destroy cancer cells selectively while

More than 1,750 young high school students from all over Catalonia participate in the launch of the second edition of “Reimagine Science: clinical trials, research and drug development” programme by

New pen-side test allows for highly specific, sensitive detection of infected animals or contaminated pig-derived products